Search Within

GME, Medicine

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (183)
  2. Journal Article (144)
  3. Research Letter (9)
  4. Review (3)
  5. Correspondence (1)
Groups
  1. Biostatistics Service (340)
  2. Epidemiology and Biostatistics (340)
  3. Graduate Medical Education (340)
  4. Department of Medicine (328)
  5. Hematologic Malignancies, Division of (224)
  6. Hematology-Oncology Fellows (214)

More Groups

People
  1. Gunjan Shah (93)
  2. Michael Scordo (93)
  3. Andriy Derkach (89)
  4. Sergio Giralt (84)
  5. Malin Hultcrantz (69)
  6. Kylee Maclachlan (67)

More People

Years
  1. 2025 (23)
  2. 2024 (85)
  3. 2023 (114)
  4. 2022 (72)
  5. 2021 (24)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (76)
  2. Blood (64)
  3. Clinical Lymphoma, Myeloma and Leukemia (24)
  4. Clinical Cancer Research (13)
  5. Annals of Oncology (12)
  6. Blood Advances (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. American Society of Hematology (74)
  3. Elsevier Inc. (45)
  4. Nature Publishing Group (29)
  5. Oxford University Press (20)
  6. American Association for Cancer Research (17)

More Publishers

Results (340)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Carfilzomib, lenalidomide and dexamethasone (KRd) vs bortezomib, lenalidomide, and dexamethasone (VRd) as induction therapy in newly diagnosed high-risk multiple myeloma
    Meeting Abstract

    Tan, C.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Patel, D.; Maclachlan, K. H.; Lahoud, O. B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Individualized treatment-adjusted risk stratification in newly diagnosed multiple myeloma
    Meeting Abstract

    Maura, F.; Rajanna, A. R.; Derkach, A.; Ziccheddu, B.; Weinhold, N.; Maclachlan, K. H.; Diamond, B.; Davies, F. E.; Boyle, E.; Walker, B. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in relapsed/refractory large B cell lymphoma (R/R LBCL): Real world outcomes in a multicenter retrospective study
    Meeting Abstract

    Qualls, D.; Buege, M. J.; Dao, P.; Caimi, P. F.; Rutherford, S. C.; Wehmeyer, G.; Romancik, J. T.; Leslie, L. A.; Merrill, M. H.; Crombie, J. L.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Stem cell autograft minimal residual disease negativity improves outcomes after autotransplant for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Hultcrantz, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Exocrine and endocrine pancreatic insufficiency induced by immune checkpoint inhibitors: A case-control study
    Meeting Abstract

    Satish, D.; Lin, I. H.; Flory, J.; Gerdes, H.; Faleck, D. M.
    American Journal of Gastroenterology (2022)

    Fulltext@MSK | Save
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Technical feasibility of salvage endoscopic submucosal dissection after chemoradiation for locally advanced rectal adenocarcinoma
    Journal Article

    Leung, G.; Nishimura, M.; Hingorani, N.; Lin, I. H.; Weiser, M. R.; Garcia-Aguilar, J.; Pappou, E. P.; Paty, P. B.; Schattner, M. A.
    Gastrointestinal Endoscopy (2022)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Meeting Abstract

    Keane, F.; Park, W.; Varghese, A.; Balogun, F.; Yu, K.; El Dika, I.; Khalil, D.; Kelsen, D. P.; Reidy-Lagunes, D.; Ku, G. Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets
    Journal Article

    Shah, U. A.; Maclachlan, K. H.; Derkach, A.; Salcedo, M.; Barnett, K.; Caple, J.; Blaslov, J.; Tran, L.; Ciardiello, A.; Burge, M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save